Advanced search
Publication Cover
Rare Diseases Volume 2, 2014 - Issue 1
Journal homepage
1,222
Views
11
CrossRef citations to date
0
Altmetric
Addendum

Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease

Shuling Guo Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA
,
Sheri L Booten Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA
,
Andrew Watt Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA
,
Luis Alvarado Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA
,
Susan M Freier Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA
,
Jeffery H Teckman Department of Pediatrics; St. Louis University School of Medicine; St. Louis, MO USA
,
Michael L McCaleb Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA
&
Brett P Monia Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USACorrespondence[email protected]
 show all
Article: e28511 | Received 27 Jan 2014, Accepted 11 Mar 2014, Published online: 12 Mar 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.